Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT02057783
Recruiting Not applicable

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension

NCT02057783 · tracked via the Priya Life Science France tracker
Sponsor
AGIR à Dom
Phase
Not applicable
Started
2015-03-26
Last updated
2025-02-20

Condition(s) studied

Hypertension, Resistant to Conventional TherapySleep Apnea

Investigational drug(s) / intervention(s)

Physical activity

Physical activity: Physical activity will carry out 3 times per week during 12 weeks for intervention arm

Study summary

Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patient with an obstructive sleep apnea (apnea-hypopnea index \> or equal to 15) * Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents * Ambulatory patient Exclusion Criteria: * Acute hepatic failure, biliary cirrhosis, cholestasis * Acute hypertension (SBP\>= 180 mmHg and/or DBP \>= 110 mmHg) * Contraindication to CPAP treatment

Primary outcome measure(s)

  • Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring — To baseline at 12 weeks
    Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring

Trial sites (5)

FacilityCityRegionStatus
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Québec Canada Recruiting
Hopital Universitaire de Grenoble La Tronche France Recruiting
Clinique Pasteur Toulouse France Recruiting
Hopitaux Universitaires de Genève Geneva Switzerland Withdrawn
Centre Hospitalier Universitaire Vaudois Lausanne Switzerland Withdrawn

More AGIR à Dom trials in France

Impact of Tele-visit on Patients Continous Positive Airway Pressure (CPAP) Follow-up by Home Care Provider Active, not recruiting

Other trials for the same condition

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device Active, not recruiting
Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS) Recruiting
New Approach in the Study of the Autonomic Nervous System Through Cardiac Variability in Sleep Apnea Syndrome. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02057783 on ClinicalTrials.gov ↗ ← All trials in France